loading page

A case of type 2 diabetes mellitus leading to euglycemic diabetic ketoacidosis in 3 days after starting sodium-glucose cotransporter 2 inhibitor while on a very-low-carbohydrate diet
  • +11
  • Ayumi Inoue,
  • Akihiro Katayama,
  • Mihiro Sue,
  • Momoka Hasegawa,
  • Megumi Maeda,
  • Masaki Matoba,
  • Takahiro Ishii,
  • Remi Kuribayashi,
  • Masafumi Tenta,
  • Yuichi Matsushita,
  • Masaya Takeda,
  • Izumi Iseda,
  • Toshiyuki Wakatsuki,
  • Kazuyuki Hida
Ayumi Inoue
Okayama Medical Center

Corresponding Author:[email protected]

Author Profile
Akihiro Katayama
Okayama Medical Center
Author Profile
Mihiro Sue
Okayama Medical Center
Author Profile
Momoka Hasegawa
Okayama Medical Center
Author Profile
Megumi Maeda
Okayama Medical Center
Author Profile
Masaki Matoba
Okayama Medical Center
Author Profile
Takahiro Ishii
Okayama Medical Center
Author Profile
Remi Kuribayashi
Okayama Medical Center
Author Profile
Masafumi Tenta
Okayama Medical Center
Author Profile
Yuichi Matsushita
Okayama Medical Center
Author Profile
Masaya Takeda
Okayama Medical Center
Author Profile
Izumi Iseda
Okayama Medical Center
Author Profile
Toshiyuki Wakatsuki
Okayama Medical Center
Author Profile
Kazuyuki Hida
Okayama Medical Center
Author Profile

Abstract

This paper presents a case with type 2 diabetes mellitus on a very low-carbohydrate diet who developed euglycemic diabetic ketoacidosis (EDKA) 3 days after starting sodium-glucose cotransporter 2 inhibitors (SGLT2i). When initiating SGLT2i, healthcare providers should confirm the implementation of a low-carbohydrate diet and provide intensive guidance to prevent EDKA.
22 Jul 2022Submitted to Clinical Case Reports
23 Jul 2022Submission Checks Completed
23 Jul 2022Assigned to Editor
01 Aug 2022Reviewer(s) Assigned
06 Sep 2022Review(s) Completed, Editorial Evaluation Pending
06 Sep 2022Editorial Decision: Revise Minor
26 Sep 20221st Revision Received
27 Sep 2022Submission Checks Completed
27 Sep 2022Assigned to Editor
27 Sep 2022Review(s) Completed, Editorial Evaluation Pending
15 Oct 2022Editorial Decision: Accept